Jiayu Ling

1.4k total citations · 1 hit paper
39 papers, 597 citations indexed

About

Jiayu Ling is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jiayu Ling has authored 39 papers receiving a total of 597 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 21 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jiayu Ling's work include Colorectal and Anal Carcinomas (13 papers), Colorectal Cancer Treatments and Studies (13 papers) and Colorectal Cancer Surgical Treatments (12 papers). Jiayu Ling is often cited by papers focused on Colorectal and Anal Carcinomas (13 papers), Colorectal Cancer Treatments and Studies (13 papers) and Colorectal Cancer Surgical Treatments (12 papers). Jiayu Ling collaborates with scholars based in China, Australia and United States. Jiayu Ling's co-authors include Yue Cai, Huabin Hu, Jianwei Zhang, Yanhong Deng, Zehua Wu, Jianxia Li, Shaofeng An, Yin Xiao, Yan Gao and Yanhong Deng and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Cell and Oncotarget.

In The Last Decade

Jiayu Ling

36 papers receiving 592 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer

2023 176 citations Jianxia Li, Cheng Wu et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiayu Ling China	10	321	142	134	119	113	39	597
Woo Ram Kim South Korea	12	279 0.9×	186 1.3×	136 1.0×	103 0.9×	87 0.8×	33	512
Stacey L. Doran United States	8	362 1.1×	171 1.2×	243 1.8×	78 0.7×	101 0.9×	15	627
Hyang Mi Ko Canada	14	144 0.4×	167 1.2×	47 0.4×	103 0.9×	178 1.6×	44	636
Tse-Ching Chen Taiwan	15	217 0.7×	160 1.1×	66 0.5×	204 1.7×	131 1.2×	21	629
Amisha Desai United Kingdom	11	101 0.3×	177 1.2×	243 1.8×	54 0.5×	46 0.4×	18	660
Dominic W. Lai United States	12	150 0.5×	85 0.6×	78 0.6×	87 0.7×	114 1.0×	24	433
Junsik Park South Korea	11	263 0.8×	42 0.3×	218 1.6×	78 0.7×	41 0.4×	59	532
Nicole Izykowski Germany	12	130 0.4×	112 0.8×	82 0.6×	115 1.0×	182 1.6×	14	548
Ning Kang China	14	133 0.4×	115 0.8×	212 1.6×	79 0.7×	105 0.9×	45	524
Douglas J. Grider United States	13	126 0.4×	185 1.3×	44 0.3×	50 0.4×	81 0.7×	69	427

Countries citing papers authored by Jiayu Ling

Since Specialization

Citations

This map shows the geographic impact of Jiayu Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiayu Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiayu Ling more than expected).

Fields of papers citing papers by Jiayu Ling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiayu Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiayu Ling. The network helps show where Jiayu Ling may publish in the future.

Co-authorship network of co-authors of Jiayu Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Jiayu Ling. A scholar is included among the top collaborators of Jiayu Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiayu Ling. Jiayu Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Long, Wei Zheng, Cai-Yun Wei, Jiayu Ling, & Qingtao Kong. (2025). Associations of body roundness index and sugar-sweetened beverage consumption with psychological symptoms in adolescents: a multicenter cross-sectional survey based on Chinese adolescents aged 12–18 years old. Frontiers in Nutrition. 12. 1505491–1505491.

Sun, Xiaojie, Ye Zhu, Nan Zhang, et al.. (2024). Prognostic value of serial coronary computed tomography angiography-derived perivascular fat-attenuation index and plaque volume in patients with suspected coronary artery disease. Clinical Radiology. 79(8). 599–607. 2 indexed citations

Wu, Zehua, Jianxia Li, Chao Wang, et al.. (2024). PD-1 blockade plus COX inhibitors in dMMR metastatic colorectal cancer: Clinical, genomic, and immunologic analyses from the PCOX trial. Med. 5(8). 998–1015.e6. 7 indexed citations

Zhu, Zhongyu, Peng Yu, Yuying Wu, et al.. (2023). Sex Specific Global Burden of Osteoporosis in 204 Countries and Territories, from 1990 to 2030: An Age-Period-Cohort Modeling Study. The journal of nutrition health & aging. 27(9). 767–774. 35 indexed citations

Li, Jianxia, Cheng Wu, Huabin Hu, et al.. (2023). Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer. Cancer Cell. 41(6). 1152–1169.e7. 176 indexed citations breakdown →

Ling, Jiayu, Lishuo Shi, Yandong Zhao, et al.. (2023). Neoadjuvant versus adjuvant imatinib in primary localized gastrointestinal stromal tumor. Journal of Gastrointestinal Oncology. 14(1). 73–84.

Wu, Zehua, Lishuo Shi, Jianwei Zhang, et al.. (2022). Aprepitant plus palonosetron versus dexamethasone plus palonosetron in preventing chemotherapy-induced nausea and vomiting in patients with moderate-emetogenic chemotherapy: A randomized, open-label, phase 3 trial. EClinicalMedicine. 49. 101480–101480. 4 indexed citations

Zhang, Jianwei, Xiaoyu Xie, Zehua Wu, et al.. (2021). Mucinous Adenocarcinoma Predicts Poor Response and Prognosis in Patients With Locally Advanced Rectal Cancer: A Pooled Analysis of Individual Participant Data From 3 Prospective Studies. Clinical Colorectal Cancer. 20(4). e240–e248. 17 indexed citations

Zhang, Jianwei, Huabin Hu, Yue Cai, et al.. (2021). mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis. Clinical Colorectal Cancer. 21(1). e12–e20. 5 indexed citations

10.

Xie, Xiaoyu, Jianwei Zhang, Huabin Hu, et al.. (2020). Efficacy and Safety of Regorafenib in Combination with Chemotherapy as Second-Line Treatment in Patients with Metastatic Colorectal Cancer: A Network Meta-Analysis and Systematic Literature Review. Advances in Therapy. 37(10). 4233–4248. 5 indexed citations

11.

Li, Jianxia, Jianwei Zhang, Huabin Hu, et al.. (2020). <p>Gene Expression Signature to Predict Prognosis and Adjuvant Chemosensitivity of Colorectal Cancer Patients</p>. Cancer Management and Research. Volume 12. 3301–3310. 5 indexed citations

12.

Hu, Huabin, Zehua Wu, Chao Wang, et al.. (2020). Duration of FOLFOX Adjuvant Chemotherapy in High-Risk Stage II and Stage III Colon Cancer With Deficient Mismatch Repair. Frontiers in Oncology. 10. 579478–579478. 6 indexed citations

13.

Wu, Zehua, Huabin Hu, Jianwei Zhang, et al.. (2020). PD-1 blockade combined with COX inhibitor in patients with MSI-H/dMMR or high TMB, advanced or metastatic colorectal cancer (PCOX study).. Journal of Clinical Oncology. 38(4_suppl). 111–111. 3 indexed citations

14.

Ling, Jiayu, et al.. (2019). [Effect of enterostomy on analgesic pattern in patients with advanced digestive tract cancer].. PubMed. 22(12). 1159–1164. 1 indexed citations

15.

Ling, Jiayu, et al.. (2018). Accelerated Step-Up Infliximab Use Is Associated with Sustained Primary Response in Pediatric Crohn’s Disease. Digestive Diseases and Sciences. 63(4). 1003–1010. 6 indexed citations

16.

Li, Yanhong, Yonghua Cai, Jiayu Ling, et al.. (2016). Application and comparison of different implanted ports in malignant tumor patients. World Journal of Surgical Oncology. 14(1). 251–251. 13 indexed citations

17.

Zhang, Jianwei, Yue Cai, Huabin Hu, et al.. (2015). Nomogram basing pre-treatment parameters predicting early response for locally advanced rectal cancer with neoadjuvant chemotherapy alone: a subgroup efficacy analysis of FOWARC study. Oncotarget. 7(4). 5053–5062. 9 indexed citations

18.

Zhen, Zijun, et al.. (2013). Impact of HLA-E gene polymorphism on HLA-E expression in tumor cells and prognosis in patients with stage III colorectal cancer. Medical Oncology. 30(1). 482–482. 30 indexed citations

19.

An, Shaofeng, Jiayu Ling, Yan Gao, & Yin Xiao. (2011). Effects of varied ionic calcium and phosphate on the proliferation, osteogenic differentiation and mineralization of human periodontal ligament cells in vitro. Journal of Periodontal Research. 47(3). 374–382. 49 indexed citations

20.

Stroop, William G., et al.. (2000). PCR assessment of HSV-1 corneal infection in animals treated with rose bengal and lissamine green B.. PubMed. 41(8). 2096–102. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact